心血管疾病(CVD)是全球领先的健康问题,有效的初级预防战略对于减轻其影响至关重要。这篇综合综述研究了当前心血管疾病一级预防的风险评估策略,强调早期识别和干预对降低发病率的重要性。传统的危险因素,如高血压,高脂血症,吸烟,生活方式的选择与新兴因素一起讨论,包括遗传易感性和生物标志物。审查评估了各种风险评估工具和模型,比如弗雷明汉风险评分,动脉粥样硬化CVD风险计算器,QRISK,和雷诺兹风险评分,强调他们的方法,优势,和限制。此外,这篇评论探讨了生活方式的改变,包括饮食变化,身体活动,体重管理,戒烟,和药物干预措施,如他汀类药物和抗高血压药。对不同人群的特殊考虑,包括老年人,女人,那些有心血管疾病家族史的人,已解决。还讨论了心血管风险评估的未来方向,专注于技术进步和个性化医疗。这篇综述旨在通过对风险评估策略的全面分析,加强有效一级预防措施的实施,改善心血管健康结果。
Cardiovascular disease (CVD) is a leading global health concern, and effective primary prevention strategies are essential to mitigate its impact. This comprehensive review examines current risk assessment strategies for primary prevention of CVD, emphasizing the importance of early identification and intervention to reduce disease incidence. Traditional risk factors such as hypertension, hyperlipidemia, smoking, and lifestyle choices are discussed alongside emerging factors, including genetic predispositions and biomarkers. The review evaluates various risk assessment tools and models, such as the Framingham risk score, atherosclerotic CVD risk calculator, QRISK, and Reynolds risk score, highlighting their methodologies, strengths, and limitations. Additionally, the review explores lifestyle modifications, including dietary changes, physical activity, weight management, smoking cessation, and pharmacological interventions like statins and antihypertensives. Special considerations for different populations, including the elderly, women, and those with a family history of CVD, are addressed. Future directions in cardiovascular risk assessment are also discussed, focusing on technological advancements and personalized medicine. This review aims to enhance the implementation of effective primary prevention measures and improve cardiovascular health outcomes by providing a thorough analysis of risk assessment strategies.